IGF2BP1 and cancer: A significant positive correlation was detected between IGF2BP1 expression and MSI in cancers such as KICH, LUSC, MESO, OV, and SARC; while, a significant negative correlation between IGF2BP1 expression and MSI was observed in COAD.